The short answer
Reviewing adequate dietary fiber can be part of constipation care during hydromorphone treatment. This does not mean hydromorphone creates a higher nutrient requirement or that adding bulk fiber will treat established opioid constipation.
What this answer covers
Ordinary dietary fiber intake versus bulk-forming supplements or treatment of severe constipation.
- Supplement or preparation
- Fiber
- Medication ingredient
- hydromorphone
The medicine can slow the bowel
Hydromorphone can cause severe constipation. Its prescribing information calls for bowel-management advice and guidance about when to seek medical attention.
Normal intake is a reasonable care topic
An opioid-constipation guideline recommends standard fluid and fiber intake, while acknowledging a lack of direct trials for these non-drug measures. It does not establish a hydromorphone-specific amount.
More fiber is not automatically better
Maintaining normal dietary intake differs from adding a bulk-forming product to treat established opioid constipation. Symptoms may require a separate bowel-treatment plan rather than continued increases in fiber.
Arrange a bowel plan
Discuss constipation, current fiber intake and any fluid restrictions with the care team. Seek advice for severe or persistent symptoms. No special fiber-to-hydromorphone timing interval or automatic high-fiber dose is established.
Evidence and practical considerations
Timing & monitoring
Conditional bowel-care review of adequate ordinary intake, not depletion, increased nutrient requirement, fixed fiber dose or proven sole treatment for opioid constipation.
- Exact scope
- Ordinary dietary fiber intake versus bulk-forming supplements or treatment of severe constipation. with Hydromorphone RxCUI3423 IN; HCl oral immediate-release, extended-release and injected products distinguished.
- Medication form and route
- oral medication; intravenous medication; intramuscular medication; subcutaneous medication; oral supplement
What remains uncertain
- No unmeasured pair incidence, blanket class transfer or arbitrary spacing interval.
Factors that may matter: Preparation; Dose; Other medicines; Organ function.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed hydromorphone
Opioid respiratory depression and additive CNS-depressant risk; general serotonergic-drug warning. Constipation can be severe. Hydromorphone is extensively glucuronidated.
How this applies: Exact hydromorphone RxCUI 3423 IN, with stated salt/formulation/route bridge.
No supplement-specific incidence. Oral, injected and extended-release products differ; oral cannabinoid experiments cannot establish every route or formulation.
Source 2: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed hydromorphone
Opioid respiratory depression and additive CNS-depressant risk; general serotonergic-drug warning. Constipation can be severe. Hydromorphone is extensively glucuronidated.
How this applies: Exact hydromorphone RxCUI 3423 IN, with stated salt/formulation/route bridge.
No supplement-specific incidence. Oral, injected and extended-release products differ; oral cannabinoid experiments cannot establish every route or formulation.
Source 3: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed hydromorphone
Opioid respiratory depression and additive CNS-depressant risk; general serotonergic-drug warning. Constipation can be severe. Hydromorphone is extensively glucuronidated.
How this applies: Exact hydromorphone RxCUI 3423 IN, with stated salt/formulation/route bridge.
No supplement-specific incidence. Oral, injected and extended-release products differ; oral cannabinoid experiments cannot establish every route or formulation.
Source 4: clinical practice guideline
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: People with opioid-induced constipation.
Recommends normal fluid/fiber intake while acknowledging lack of direct nonpharmacological OIC efficacy studies in its review.
How this applies: Guideline recommendation, not a hydromorphone-specific fiber trial or proof that increasing bulk treats established opioid constipation.
Guideline recommendation, not a hydromorphone-specific fiber trial or proof that increasing bulk treats established opioid constipation.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Prepared exact hydromorphone article with formulation-specific evidence and uncertainty. | |
| Research summary published |
Article revision: 378735a2143945de
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.